Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 07:32 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Polar Capital Holdings Plc | 3,027,705 5.2% | 3,027,705 (New Position) | View |
| 2021-02-12 09:34 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | RTW INVESTMENTS LP | 5,387,513 9.26% | 1,986,079 (+58.39%) | View |
| 2021-02-12 08:07 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Avoro Capital Advisors LLC | 4,365,000 7.5% | 4,365,000 (New Position) | View |
| 2021-02-11 4:21 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | BRANDES INVESTMENT PARTNERS LP | 2,961,878 5.08% | -690,070 (-18.90%) | View |
| 2020-03-04 4:30 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Vivo Opportunity LLC | 2,882,824 6.2% | 2,882,824 (New Position) | View |
| 2020-02-14 1:48 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | RTW INVESTMENTS LP | 3,401,434 9.08% | 5,279 (+0.16%) | View |
| 2020-02-13 5:26 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Broadfin Capital LLC | 1,029,012 2.75% | -2,073,661 (-66.83%) | View |
| 2020-02-13 12:38 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Flynn James E | 0 0% | -2,722,241 (Position Closed) | View |
| 2020-01-07 2:10 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | BRANDES INVESTMENT PARTNERS LP | 3,651,948 9.75% | -788,102 (-17.75%) | View |
| 2019-12-30 3:46 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | RTW INVESTMENTS LP | 3,396,155 9.07% | 3,396,155 (New Position) | View |
| 2019-12-05 11:46 am Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | BRANDES INVESTMENT PARTNERS LP | 4,440,050 11.86% | -2,679,004 (-37.63%) | View |
| 2019-10-04 5:32 pm Unchanged | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Broadfin Capital LLC | 3,102,673 8.3% | 0 (Unchanged) | View |
| 2019-10-04 4:18 pm Unchanged | 13D | AVADEL PHARMACEUTICALS PLC SPO AVDL | Broadfin Capital LLC | 3,102,673 8.3% | 0 (Unchanged) | View |